Open-Label Pilot Study of Lisdexamfetamine for Cocaine Dependence

Summary

The proposed protocol is an open-label pilot study of the treatment of cocaine dependence using lisdexamfetamine (LDX), a prodrug of d-amphetamine. The investigators plan to enroll 12 patients in an eight-week open-label trial to obtain preliminary data regarding the safety, tolerability, and potential utility of lisdexamfetamine for treatment of cocaine dependence and to determine an effective dosage range.

Timeline

Start

2011-12

Primary completion

2013-12

Completion

2013-12

Drugs

Indications